☰

Angelika Brekman, Ph.D. - Publications

Affiliations: 
2011 Biochemistry City University of New York, New York, NY, United States 
Area:
Biochemistry, Molecular Biology, Oncology
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Kundu N, Brekman A, Kim JY, Xiao G, Gao C, Bargonetti J. Estrogen-activated MDM2 disrupts mammary tissue architecture through a p53-independent pathway. Oncotarget. PMID 28615518 DOI: 10.18632/Oncotarget.18147  0.713
2012 Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J. Correction: A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation Breast Cancer Research. 14. DOI: 10.1186/Bcr3130  0.64
2011 Brekman A, Singh KE, Polotskaia A, Kundu N, Bargonetti J. A p53-independent role of Mdm2 in estrogen-mediated activation of breast cancer cell proliferation. Breast Cancer Research : Bcr. 13: R3. PMID 21223569 DOI: 10.1186/Bcr2804  0.69
2010 Boamah EK, Brekman A, Tomasz M, Myeku N, Figueiredo-Pereira M, Hunter S, Meyer J, Bhosle RC, Bargonetti J. DNA adducts of decarbamoyl mitomycin C efficiently kill cells without wild-type p53 resulting from proteasome-mediated degradation of checkpoint protein 1. Chemical Research in Toxicology. 23: 1151-62. PMID 20536192 DOI: 10.1021/Tx900420K  0.531
2010 Polotskaia A, Brekman A, Bargonetti J. Abstract 838: Mdm2 and oncogenic mutant p53 as biomarkers for potential drug targets in estrogen receptor positive and triple negative breast cancer Cancer Research. 70: 838-838. DOI: 10.1158/1538-7445.Am10-838  0.713
2008 Arva NC, Talbott KE, Okoro DR, Brekman A, Qiu WG, Bargonetti J. Disruption of the p53-Mdm2 complex by nutlin-3 reveals different cancer cell phenotypes Ethnicity and Disease. 18: S2-1-S2-8. PMID 18646312  0.683
Show low-probability matches.